Dopamine rushes, withdrawals, and detoxes are trending among wellness gurus online. But experts say the science behind the ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The mechanism of the drug's beneficial effect on cardiovascular disease remains to be determined. Recently, timed-release bromocriptine (Cycloset), a sympatholytic dopamine D 2 receptor agonist ...

The US Food and Drug Administration (FDA) has approved Supernus Pharmaceuticals’ Onapgo (apomorphine hydrochloride) injection ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

Also, there was a reduction in daytime sleepiness with the drug which if confirmed in later studies would differentiate it from dopamine agonist drugs that are sometimes used alongside L-DOPA.

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

After 3 months, alteration in other antidiabetic medications was permitted. Overall, there were 8.6% serious adverse events in the Cycloset group and 9.6% serious adverse events in the placebo ...